AR-CHOP-21

Leiter: Herr Univ. Prof. Dr. Georg Lenz

 

Rekrutierung gestartet

A Phase 3, Randomizes, Double-Blind, Placebo-Controlled, Multicenter Study Comparing the Efficacy and Safety of Acalabrutinib plus R-CHOP Versus Placebo plus R-CHOP in Adult Participants e 65 Years with Preiously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma

 
Zusätzliche Dokumente
 

Herr Univ. Prof. Dr. Georg Lenz

Universitätsklinikum Münster

E-Mail senden